Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Swine CD105 Monoclonal antibody

Cat. No.VD10H85

Product TypeAnimal-targeted Antibodies

Size

Inquiry Now Add to Inquiry List

Product Overview

O17H85 monoclonal antibody is specific for Swine CD105, also know as Endoglin and ORW1. It can be applied for Flow Cytometry (FC).

Specifications

Application FC

Clonality Monoclonal Antibody

Classification Primary Antibody

Clone O17H85

Host Mouse

Target Species Swine

Species Reactivity Swine

Specificity Swine CD105

Isotype IgG2a

Purity ≥ 90% (SDS-PAGE)

Conjugation Unconjugated

Buffer Phosphate buffered saline

Physical State Liquid

Target Information

Cluster of Differentiation 105 (CD105), also known as Endoglin and ORW1 is a type I membrane glycoprotein located on cell surfaces and is part of the TGF beta receptor complex. It is highly expressed on endothelial cells of tissues undergoing angiogenesis. CD105 plays an important role in angiogenesis; therefore, making it an important protein for tumor growth; survival and metastasis of cancer cells to other locations in the body.

Target Swine CD105

Target Synonym ENG; Endoglin; Eng; AI528660; AI662476; Endo; S-endoglin; END; HHT1; ORW1; endoglin

Gene ID 397096

UniProt ID P37176

Shipping and Storage

This product is shipped at ambient temperature. It is recommended to aliquot and store at 2-8°C on receipt (up to 12 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Fonsatti, Ester, et al. "Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer." Journal of translational medicine 2 (2004): 1-7.